These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 9579704)
1. Statistical approaches to trial durations in episodic affective illness. Post RM; L'Herrou T; Luckenbaugh DA; Frye MA; Leverich GS; Mikalauskas K Psychiatry Res; 1998 Mar; 78(1-2):71-87. PubMed ID: 9579704 [TBL] [Abstract][Full Text] [Related]
2. Unique design issues in clinical trials of patients with bipolar affective disorder. Post RM; Luckenbaugh DA J Psychiatr Res; 2003; 37(1):61-73. PubMed ID: 12482471 [TBL] [Abstract][Full Text] [Related]
3. ECNP consensus meeting. Bipolar depression. Nice, March 2007. Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566 [TBL] [Abstract][Full Text] [Related]
4. Long-term treatment of bipolar disorder with lamotrigine. Calabrese JR; Shelton MD; Rapport DJ; Kimmel SE; Elhaj O J Clin Psychiatry; 2002; 63 Suppl 10():18-22. PubMed ID: 12392349 [TBL] [Abstract][Full Text] [Related]
5. Impact of trial design on the estimation of drug potency and power in clinical trials of haemophilia with inhibitors. Larsen MS; Juul RV; Kreilgaard M; Kristensen AT; Simonsson USH Eur J Pharm Sci; 2018 Oct; 123():531-538. PubMed ID: 30077714 [TBL] [Abstract][Full Text] [Related]
6. Reading reports of clinical trial results. Kane JM J Clin Psychiatry; 2005 May; 66(5):653. PubMed ID: 15889955 [No Abstract] [Full Text] [Related]
7. A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures. Post RM; Weiss SR Mol Neurobiol; 1996 Aug; 13(1):33-60. PubMed ID: 8892335 [TBL] [Abstract][Full Text] [Related]
8. Evolution of psychopharmacology trial design and analysis: six decades in the making. Leon AC J Clin Psychiatry; 2011 Mar; 72(3):331-40. PubMed ID: 21450153 [TBL] [Abstract][Full Text] [Related]
9. Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder. Goldberg JF; Bowden CL; Calabrese JR; Ketter TA; Dann RS; Frye MA; Suppes T; Post RM Biol Psychiatry; 2008 Jan; 63(1):125-30. PubMed ID: 17543894 [TBL] [Abstract][Full Text] [Related]
10. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Scheffer RE; Kowatch RA; Carmody T; Rush AJ Am J Psychiatry; 2005 Jan; 162(1):58-64. PubMed ID: 15625202 [TBL] [Abstract][Full Text] [Related]
11. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. Keck PE; Versiani M; Potkin S; West SA; Giller E; Ice K; Am J Psychiatry; 2003 Apr; 160(4):741-8. PubMed ID: 12668364 [TBL] [Abstract][Full Text] [Related]
12. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Bowden CL; Calabrese JR; Sachs G; Yatham LN; Asghar SA; Hompland M; Montgomery P; Earl N; Smoot TM; DeVeaugh-Geiss J; Arch Gen Psychiatry; 2003 Apr; 60(4):392-400. PubMed ID: 12695317 [TBL] [Abstract][Full Text] [Related]
13. Meta-analysis combining parallel and crossover trials using generalised estimating equation method. Curtin F Res Synth Methods; 2017 Sep; 8(3):312-320. PubMed ID: 28585280 [TBL] [Abstract][Full Text] [Related]
14. Course and cognitive outcome in major affective disorder. Kessing LV Dan Med J; 2015 Nov; 62(11):B5160. PubMed ID: 26522485 [TBL] [Abstract][Full Text] [Related]
15. Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials. Weisler RH; Hirschfeld R; Cutler AJ; Gazda T; Ketter TA; Keck PE; Swann A; Kalali A; CNS Drugs; 2006; 20(3):219-31. PubMed ID: 16529527 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder. Suppes T; Eudicone J; McQuade R; Pikalov A; Carlson B J Affect Disord; 2008 Apr; 107(1-3):145-54. PubMed ID: 17904226 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the efficacy and safety of eslicarbazepine acetate in acute mania and prevention of recurrence: experience from multicentre, double-blind, randomised phase II clinical studies in patients with bipolar disorder I. Grunze H; Kotlik E; Costa R; Nunes T; Falcão A; Almeida L; Soares-da-Silva P J Affect Disord; 2015 Mar; 174():70-82. PubMed ID: 25484179 [TBL] [Abstract][Full Text] [Related]
18. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study. Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495 [TBL] [Abstract][Full Text] [Related]
19. Psychosocial and psychophysiologic aspects of reproduction: the need for improved study design. Ellsworth LR; Shain RN Fertil Steril; 1985 Oct; 44(4):449-52. PubMed ID: 3902511 [TBL] [Abstract][Full Text] [Related]
20. Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression. Goldberg JF; Burdick KE; Endick CJ Am J Psychiatry; 2004 Mar; 161(3):564-6. PubMed ID: 14992985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]